| Delivering the messenger: advances in technologies for therapeutic mRNA delivery PS Kowalski, A Rudra, L Miao, DG Anderson Molecular Therapy 27 (4), 710-728, 2019 | 1026 | 2019 |
| Total synthesis of bryostatin 1 GE Keck, YB Poudel, TJ Cummins, A Rudra, JA Covel Journal of the American Chemical Society 133 (4), 744-747, 2011 | 182 | 2011 |
| Ionizable amino‐polyesters synthesized via ring opening polymerization of tertiary amino‐alcohols for tissue selective mRNA delivery PS Kowalski, U Capasso Palmiero, Y Huang, A Rudra, R Langer, ... Advanced materials 30 (34), 1801151, 2018 | 120 | 2018 |
| Molecular modeling, total synthesis, and biological evaluations of C9‐deoxy bryostatin 1 GE Keck, YB Poudel, A Rudra, JC Stephens, N Kedei, NE Lewin, ... Angewandte Chemie International Edition 49 (27), 4580-4584, 2010 | 64 | 2010 |
| Role of the C< sub> 8</sub>< i> gem</i>-dimethyl group of bryostatin 1 on its unique pattern of biological activity GE Keck, YB Poudel, A Rudra, JC Stephens, N Kedei, NE Lewin, ... Bioorganic & medicinal chemistry letters 22 (12), 4084-4088, 2012 | 29 | 2012 |
| Trends in therapeutic conjugates: Bench to clinic A Rudra, J Li, R Shakur, S Bhagchandani, R Langer Bioconjugate chemistry 31 (3), 462-473, 2020 | 28 | 2020 |
| Biological Profile of the Less Lipophilic and Synthetically More Accessible Bryostatin 7 Closely Resembles That of Bryostatin 1 N Kedei, NE Lewin, T Géczy, J Selezneva, DC Braun, J Chen, ... ACS chemical biology 8 (4), 767-777, 2013 | 28 | 2013 |
| Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogues in LNCaP and U937 cancer cell lines provides insight into their differential … N Kedei, A Telek, AM Michalowski, MB Kraft, W Li, YB Poudel, A Rudra, ... Biochemical Pharmacology, 2012 | 25 | 2012 |
| Bromopyridone Nucleotide Analogues, Anoxic Selective Radiosensitizing Agents That Are Incorporated in DNA by Polymerases A Rudra, D Hou, Y Zhang, J Coulter, H Zhou, TL DeWeese, ... The Journal of Organic Chemistry, 2015 | 6 | 2015 |
| Advanced technologies for the development of infectious disease vaccines A Gupta, A Rudra, K Reed, R Langer, DG Anderson Nature Reviews Drug Discovery, 2024 | 5 | 2024 |
| Saponin and fluorine-modified polycation as a versatile gene delivery system A Hasanzadeh, AH Vahabi, SE Hooshmand, ES Hosseini, BKY Azar, ... Nanotechnology 33 (44), 445101, 2022 | 5 | 2022 |
| Therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppresses atrial fibrillation N Momin, S Pabel, A Rudra, N Kumowski, IH Lee, K Mentowski, ... bioRxiv, 2024 | 2 | 2024 |
| Modulating stromal and immune cells in atrial disease N Momin, A Rudra, M Hulsmans, M Nahrendorf, MJ Schloss, IH Lee, ... US Patent WO2024233966A2, 2024 | | 2024 |
| Electromechanical Devices for the Burst Release of Indefinitely Stable Dry Powder Drugs S Krishnan, D Anderson, RS Langer, A Rudra, N Khatib, L O'keeffe US Patent App. 18/514,373, 2024 | | 2024 |
| Biodegradable lipids and formulations for intramuscular, in vitro, and ex vivo transfection of mrna DG Anderson, A Rudra, A Gupta, K Reed US Patent US20240226302A1, 2024 | | 2024 |
| Studies on the effects of various functional groups on the northern hemisphere of bryostatin through synthesis A Rudra The University of Utah, 2014 | | 2014 |
| Total synthesis and biological evaluation of bryostatin 7 GE Keck, YB Poudel, TJ Cummins, A Rudra, JA Covel, N Kedei, NE Lewin, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 243, 2012 | | 2012 |
| Synthesis of Bryostatin 1 GE Keck, YB Poudel, TJ Cummins, A Rudra, JA Covel Synfacts 2011 (05), 0464-0464, 2011 | | 2011 |
Daniel G. AndersonMassachusetts Institute of TechnologyVerified email at mit.edu
